LGM

Logos Global Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 197.64%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+197.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$811M
AUM Growth
+$266M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$24.9M
2
+$23.7M
3
+$19.7M
4
VRDN icon
Viridian Therapeutics
VRDN
+$18M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$18M

Top Sells

1
+$29.2M
2
+$27.9M
3
+$20.3M
4
CCXI
ChemoCentryx, Inc.
CCXI
+$14.9M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$11.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$88.8M 10.95%
1,300,000
-200,000
2
$82.4M 10.16%
1,700,000
-50,000
3
$61.7M 7.61%
4,135,000
+385,000
4
$48.8M 6.02%
1,397,680
-915,000
5
$46.8M 5.77%
2,797,501
6
$46.5M 5.74%
2,000,000
+300,000
7
$38.7M 4.77%
350,000
-50,000
8
$36.3M 4.48%
+5,936,666
9
$33.7M 4.16%
150,000
10
$29.1M 3.59%
1,525,000
+525,000
11
$29M 3.58%
2,287,321
-612,679
12
$28.4M 3.51%
2,971,352
-165,000
13
$26.9M 3.32%
+1,500,000
14
$25.8M 3.18%
+250,000
15
$22M 2.71%
1,085,251
+100,000
16
$20.5M 2.53%
+1,000,000
17
$18.1M 2.23%
+500,000
18
$16.4M 2.03%
+350,000
19
$15.8M 1.95%
1,950,000
20
$13.6M 1.68%
+400,000
21
$11.1M 1.37%
+850,000
22
$10.3M 1.27%
3,743,875
23
$9.96M 1.23%
+950,000
24
$9.58M 1.18%
+750,000
25
$8.45M 1.04%
+800,000
1
2